James B. Breitmeyer - Chief Executive Officer, Director at Oncternal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ONCT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James B. Breitmeyer since 11/21/2023

Holdings reported by James B. Breitmeyer for Oncternal Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 443K $220K $0.50 Jan 3, 2024 Direct
Common Stock 197K $97.5K $0.50 Jan 3, 2024 By Family Trust
Common Stock 15.4K $7.65K $0.50 Jan 3, 2024 By Spouse
Common Stock 733 $364 $0.50 Jan 3, 2024 By Child
Stock Option 28.4K Feb 14, 2024 Direct Common Stock
Stock Option 6.2K Feb 14, 2024 By Spouse Common Stock

Transactions reported by James B. Breitmeyer for Oncternal Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.